COVID-19 vaccines and blood glucose control: Friend or foe?

W Vena, S Pigni, N Betella, A Navarra… - Human Vaccines & …, 2024‏ - Taylor & Francis
Purpose To overview the recent literature regarding the relationship between COVID-19
vaccines and glycemic control. Methods Data were extracted from text and tables of all …

Assessment of the immune response in patients with insulin resistance, obesity, and diabetes to COVID-19 vaccination

J Warpechowski, P Leszczyńska, D Juchnicka… - Vaccines, 2023‏ - mdpi.com
The SARS-CoV-19 pandemic overwhelmed multiple healthcare systems across the world.
Patients with underlying medical conditions such as obesity or diabetes were particularly …

[HTML][HTML] Late in the US pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseases

WM Kühtreiber, ER Hostetter, GE Wolfe, MS Vaishnaw… - Iscience, 2024‏ - cell.com
Summary The Bacillus Calmette-Guérin vaccine has many off-target benefits, including
protection from diverse infectious diseases. As SARS-CoV-2 evolved, COVID-19 disease …

COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: A cross-sectional study

H Li, F **, X Li, Z Wang, J **ao, H Jiang… - Frontiers in …, 2023‏ - frontiersin.org
Aims Diabetes mellitus (DM), one of the most common chronic diseases in China, is a risk
factor for SARS-COV-2 infection and poor prognosis of COVID-19. The COVID-19 vaccine is …

Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the …

B Gaborit, S Fernandes, P Loubet, L Ninove, A Dutour… - Metabolism, 2023‏ - Elsevier
Background Patients with diabetes and obesity are populations at high-risk for severe
COVID-19 outcomes and have shown blunted immune responses when administered …

[HTML][HTML] Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an …

DE Malden, J Gee, S Glenn, Z Li, C Mercado, OA Ogun… - Vaccine, 2023‏ - Elsevier
Background Studies combining data from digital surveys and electronic health records
(EHR) can be used to conduct comprehensive assessments on COVID-19 vaccine safety …

SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose

X Zhang, G Si, H Lu, W Zhang, S Zheng, Z Huang, L Liu… - Virology Journal, 2022‏ - Springer
Abstract Background Omicron variant (B. 1.1. 529) is a dominant variant worldwide.
However, the risk factors for Omicron variant clearance are yet unknown. The present study …

Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors

K Subbarayan, A Al-Samadi, H Schäfer… - Cellular and Molecular …, 2024‏ - Springer
Abstract Angiotensensin-converting enzyme-2 (ACE2) is a receptor for SARS-CoV-2,
allowing the virus to enter cells. Although tumor patients infected by SARS-CoV-2 often have …

SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus

K Karavanaki, S Karanasios, A Soldatou, M Tsolia - Endocrine, 2023‏ - Springer
Abstract Adults with Diabetes Mellitus (DM) have increased risk of severe clinical
presentation during COVID-19 infection, while children and adolescents with type 1 diabetes …

Similar time course of humoral response to SARS-CoV-2 mRNA vaccines in people with and without type 1 diabetes

X Jia, F Dong, L Pyle, AW Michels, L Yu… - Diabetes Technology & …, 2023‏ - liebertpub.com
Objective: To assess whether the immunogenicity of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccines or breakthrough infection rates differ between …